Biocon acquires Cuban partner's stake in joint venture
This article was originally published in Scrip
Executive Summary
Biocon, India's largest biotech company by revenues, is to acquire Cuban partner CIMAB SA's 49% holding in their joint venture, Biocon Biopharmaceuticals, for an undisclosed sum.